GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (OSTO:ALZCUR) » Definitions » Sale Of Investment

AlzeCure Pharma AB (OSTO:ALZCUR) Sale Of Investment : kr0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is AlzeCure Pharma AB Sale Of Investment?

AlzeCure Pharma AB's sale of investment for the three months ended in Dec. 2024 was kr0.00 Mil. It means AlzeCure Pharma AB gained kr0.00 Mil from selling investments. AlzeCure Pharma AB's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Sep. 2024 ), AlzeCure Pharma AB gained the same money from selling investments in Dec. 2024 (kr0.00 Mil).


AlzeCure Pharma AB Sale Of Investment Historical Data

The historical data trend for AlzeCure Pharma AB's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzeCure Pharma AB Sale Of Investment Chart

AlzeCure Pharma AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial - - - 0.01 -

AlzeCure Pharma AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AlzeCure Pharma AB Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AlzeCure Pharma AB Sale Of Investment Related Terms

Thank you for viewing the detailed overview of AlzeCure Pharma AB's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


AlzeCure Pharma AB Business Description

Traded in Other Exchanges
Address
Halsovagen 7, Huddinge, SWE, SE 141 57
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms NeuroRestore, Alzstatin, and Painless. The company's drug candidates include; ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, ACD679, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatments of severe pain in conditions such as osteoarthritis.

AlzeCure Pharma AB Headlines

No Headlines